|
GTF2A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.75779999953296E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.08450000002591E-06 |
| Normal-vs-Stage2 |
4.262200E-03 |
| Normal-vs-Stage3 |
2.108200E-02 |
| Normal-vs-Stage4 |
4.764900E-04 |
| Stage1-vs-Stage2 |
4.630400E-01 |
| Stage1-vs-Stage3 |
1.351620E-01 |
| Stage1-vs-Stage4 |
6.010000E-01 |
| Stage2-vs-Stage3 |
6.652400E-01 |
| Stage2-vs-Stage4 |
3.946600E-01 |
| Stage3-vs-Stage4 |
2.416000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.99289999997166E-06 |
| Normal-vs-AfricanAmerican |
1.94320000002079E-06 |
| Normal-vs-Asian |
1.181030E-03 |
| Caucasian-vs-AfricanAmerican |
6.061600E-01 |
| Caucasian-vs-Asian |
4.710200E-01 |
| AfricanAmerican-vs-Asian |
5.586000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.09950001828219E-09 |
| Normal-vs-Female |
2.593600E-02 |
| Male-vs-Female |
1.335310E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.87049999999767E-05 |
| Normal-vs-Extreme_Weight |
1.59249999853728E-08 |
| Normal-vs-Obese |
1.237840E-03 |
| Normal-vs-Extreme_Obese |
4.36480000000072E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.171200E-01 |
| Normal_Weight-vs-Obese |
3.045200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.284200E-01 |
| Extreme_Weight-vs-Obese |
1.677810E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.470200E-01 |
| Obese-vs-Extreme_Obese |
5.298400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.779900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.08689999999989E-05 |
| Normal-vs-Age(61-80Yrs) |
6.36349994920238E-09 |
| Normal-vs-Age(81-100Yrs) |
2.2283999999706E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.045000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.182800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.975900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.268000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.444100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.480800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.64390001611281E-09 |
| Normal-VS-Type2 PRCC |
7.67730000000855E-05 |
| Normal-VS-KIRP CIMP |
5.588600E-01 |
| Normal-VS-Unclassified PRCC |
6.640200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.007960E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.144840E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.668350E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.198850E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.263760E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.609600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.9590999962621E-08 |
| Normal-vs-N1 |
3.831500E-02 |
| Normal-vs-N2 |
3.622400E-03 |
| N0-vs-N1 |
1.314840E-01 |
| N0-vs-N2 |
6.854200E-01 |
| N1-vs-N2 |
3.521400E-01 |
|
|
